Cryo-Cell International Overview
Valuation check: CCEL's P/E ratio is -19.45, below the Healthcare sector average of 19.01.
Get informed when a big investor buys or sells
+ Follow-19.45
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
As of the most recent data, CCEL shows a P/E ratio of -19.45. That is below the Healthcare sector average of 19.01. Scroll down for historical charts and peer comparison views.
The Healthcare sector average P/E ratio is about 19.01. Cryo-Cell International is at -19.45, which is lower that average. That is roughly 202.3% below the sector mean. Use the comparison chart on this page to see how CCEL stacks up against individual peers as well.
Investors watch CCEL's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Cryo-Cell International's latest reading is -19.45. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this p/e ratio page, Stockcircle has Cryo-Cell International's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently -19.45) with ownership activity and broader fundamentals.
The Healthcare average P/E ratio is about 19.01, while CCEL is at -19.45. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
